Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations

被引：0
|
作者：
Barbara Schwartzberg
John Lewin
Osama Abdelatif
Jacqueline Bernard
Hanadi Bu-Ali
Simon Cawthorn
Margaret Chen-Seetoo
Sheldon Feldman
Sasirekha Govindarajulu
Lyn Jones
Arne Juette
Sanjay Kavia
Robert Maganini
Simon Pain
Mike Shere
Craig Shriver
Simon Smith
Alexandra Valencia
Eric Whitacre
Roger Whitney
机构：
[1] Sarah Cannon Research Institute at Rose Medical Center,
[2] Women’s Imaging Center,undefined
[3] Tucson Pathology Associates,undefined
[4] Walter Reed National Military Medical Center,undefined
[5] Virginia Piper Cancer Institute,undefined
[6] Southmead Hospital,undefined
[7] Herbert Irving Pavilion,undefined
[8] Columbia University,undefined
[9] Montefiore Einstein Center for Cancer Care,undefined
[10] Norfolk and Norwich University Hospital,undefined
[11] Broomfield Hospital,undefined
[12] St. Alexius Breast Care Center,undefined
[13] Breast Center of Southern Arizona,undefined
来源：
Annals of Surgical Oncology | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The article “Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations”, written by Barbara Schwartzberg et al., was originally published electronically on the publisher’s internet portal (currently SpringerLink) on July 9, 2018, without open access.
引用
收藏
页码：998 / 998
相关论文
共 50 条
  • [1] Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
    Barbara Schwartzberg
    John Lewin
    Osama Abdelatif
    Jacqueline Bernard
    Hanadi Bu-Ali
    Simon Cawthorn
    Margaret Chen-Seetoo
    Sheldon Feldman
    Sasirekha Govindarajulu
    Lyn Jones
    Arne Juette
    Sanjay Kavia
    Robert Maganini
    Simon Pain
    Mike Shere
    Craig Shriver
    Simon Smith
    Alexandra Valencia
    Eric Whitacre
    Roger Whitney
    Annals of Surgical Oncology, 2018, 25 : 2958 - 2964
  • [2] Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
    Schwartzberg, Barbara
    Lewin, John
    Abdelatif, Osama
    Bernard, Jacqueline
    Bu-Ali, Hanadi
    Cawthorn, Simon
    Chen-Seetoo, Margaret
    Feldman, Sheldon
    Govindarajulu, Sasirekha
    Jones, Lyn
    Juette, Arne
    Kavia, Sanjay
    Maganini, Robert
    Pain, Simon
    Shere, Mike
    Shriver, Craig
    Smith, Simon
    Valencia, Alexandra
    Whitacre, Eric
    Whitney, Roger
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (10) : 2958 - 2964
  • [3] Phase II open-label trial investigating percutaneous laser ablation for treatment of early-stage breast cancer: MRI, pathology, and outcome correlations
    Schwartzberg, Barbara
    Lewin, John
    Abeldelatif, Osama
    Bernard, Jacqueline
    Bu-Ali, Hanadi
    Cawthorn, Simon
    Chen-Seetoo, Margaret
    Feldman, Sheldon
    Govindarajulu, Sasirekha
    Jones, Lyn
    Juette, Arne
    Kavia, Sanjay
    Maganini, Robert
    Pain, Simon
    Shere, Mike
    Shriver, Craig
    Smith, Simon
    Valencia, Alexandra
    Whitacre, Eric
    Whitney, Roger
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 283 - 284
  • [4] Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations (vol 25, pg 2958, 2018)
    Schwartzberg, Barbara
    Lewin, John
    Abdelatif, Osama
    Bernard, Jacqueline
    Bu-Ali, Hanadi
    Cawthorn, Simon
    Chen-Seetoo, Margaret
    Feldman, Sheldon
    Govindarajulu, Sasirekha
    Jones, Lyn
    Juette, Arne
    Kavia, Sanjay
    Maganini, Robert
    Pain, Simon
    Shere, Mike
    Shriver, Craig
    Smith, Simon
    Valencia, Alexandra
    Whitacre, Eric
    Whitney, Roger
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 998 - 998
  • [5] Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial
    van de Voort, Elles M. F.
    Struik, Gerson M.
    Koppert, Linetta B.
    Moelker, Adriaan
    Debets, Reno
    Yo, Glenn
    Macco, Maura J. P., V
    Sinke, Renata H. J. A.
    Franckena, Martine
    Birnie, Erwin
    Verhoef, Cornelis
    Klem, Taco M. A. L.
    BMJ OPEN, 2021, 11 (09):
  • [6] Multicenter, phase II open-label trial of percutaneous laser ablation (PLA) for 61 patients (pts) with early-stage (ES) primary breast cancer: Radiographic (MRI) and pathological correlation.
    Schwartzberg, Barbara Stewart
    Abdelatif, Osama
    Lewin, John
    Bernard, Jacqueline
    Bu-Ali, Hanadi
    Cawthorn, Simon
    Chen-Seeto, Margaret
    Feldman, Sheldon M.
    Govindarajulu, Sasirekha
    Jones, Lyn
    Juette, Arne
    Kavia, Sanjay
    Maganini, Robert
    Pain, Simon
    Shere, Mike
    Shriver, Craig D.
    Smith, Simon
    Valencia, Alexandra
    Whitacre, Eric B.
    Whitney, Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
    Del Mastro, Lucia
    Mansutti, Mauro
    Bisagni, Giancarlo
    Ponzone, Riccardo
    Durando, Antonio
    Amaducci, Laura
    Campadelli, Enrico
    Cognetti, Francesco
    Frassoldati, Antonio
    Michelotti, Andrea
    Mura, Silvia
    Urracci, Ylenia
    Sanna, Giovanni
    Gori, Stefania
    De Placido, Sabino
    Garrone, Ornella
    Fabi, Alessandra
    Barone, Carla
    Tamberi, Stefano
    Bighin, Claudia
    Puglisi, Fabio
    Moretti, Gabriella
    Arpino, Grazia
    Ballestrero, Alberto
    Poggio, Francesca
    Lambertini, Matteo
    Montemurro, Filippo
    Bruzzi, Paolo
    LANCET ONCOLOGY, 2021, 22 (10): : 1458 - 1467
  • [8] Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 x 2 factorial, randomised phase 3 trial
    Del Mastro, Lucia y
    De Placido, Sabino
    Bruzzi, Paolo
    De Laurentiis, Michele
    Boni, Corrado
    Cavazzini, Giovanna
    Durando, Antonio
    Turletti, Anna
    Nistico, Cecilia
    Valle, Enrichetta
    Garrone, Ornella
    Puglisi, Fabio
    Montemurro, Filippo
    Barni, Sandro
    Ardizzoni, Andrea
    Gamucci, Teresa
    Colantuoni, Giuseppe
    Giuliano, Mario
    Gravina, Adriano
    Papaldo, Paola
    Bighin, Claudia
    Bisagni, Giancarlo
    Forestieri, Valeria
    Cognetti, Francesco
    LANCET, 2015, 385 (9980): : 1863 - 1872
  • [9] Fluorouracil and Dose-Dense Chemotherapy in Adjuvant Treatment of Patient with Early-Stage Breast Cancer: an Open-Label, 2 x 2 Factorial, Randomised Phase III Trial
    Colle, E.
    Besse, B.
    ONCOLOGIE, 2015, 17 (7-8) : 330 - 332
  • [10] An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
    Phuong Khanh Morrow
    Murthy, Rashmi K.
    Ensor, Joe D.
    Gordon, Gilad S.
    Margolin, Kim A.
    Elias, Anthony D.
    Urba, Walter J.
    Weng, David E.
    Rugo, Hope S.
    Hortobagyi, Gabriel N.
    CANCER, 2012, 118 (17) : 4098 - 4104
12345